Pharmaceutical News and Articles

Acetaminophen Linked To Autism/ADHD, Evidence Review Argues

TUESDAY, Aug. 19, 2024 Taking acetaminophen while pregnant might increase a child s risk of autism or ADHD, a new evidence review says. Analysis of 46 prior stu

Volunteering Slows Brain Aging

TUESDAY, Aug. 19, 2025 Want to keep your brain healthy as you age Regularly volunteer some of your time to your community, neighborhood, friends or family, a ne

Stealth Biotherapeutics Resubmits New Drug Application for Elamipretide for the Treatment of Barth Syndrome

Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Pretreated Extensive-Stage Small Cell Lung Cancer

BASKING RIDGE, NJ AND RAHWAY, NJ, August 18, 2025 Ifinatamab deruxtecan (I-DXd) has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Dru

Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Redmond, WA and Princeton, NJ August 18, 2025 SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb today announced tha

FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet's Disease after Reviewing Recent Phase 2 Clinical Study Results

Soligenix, Inc. (Nasdaq SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rar

Blood Pressure Measurement Methods Have Clinically Important Variance

Differences across blood pressure (BP) measurement methods show clinically important variance in readings, according to a review published online Aug. 19 in the

FDA Approves KETARx (ketamine) for Surgical Pain Management

Hundreds May Have Been Exposed to Rabies in Wyoming Park Cabins

MONDAY, Aug. 18, 2025 Hundreds of people may have been exposed to rabies after staying in cabins infested with bats at Wyoming s Grand Teton National Park. As m

FDA Approves Ketamine Product, KETARx, for Surgical Pain Management

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management. Ketamine is the only psychedelic or psyche